Publikationsliste

Pipe SW, Hermans C, Chitlur M, Carcao M, Castaman G, Davis JA, Ducore J, Dunn AL, Escobar M, Journeycake J, Khan O, Mahlangu J, Meeks SL, Mitha IH, Négrier C, Nowak-Göttl U, Recht M, Chrisentery-Singleton T, Stasyshyn O, Vilchevska KV, Martinez LV, Wang M, Windyga J, Young G, Alexander WA, Bonzo D, Macie C, Mitchell IS, Sauty E, Wilkinson TA, Shapiro AD. Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors. HAEMOPHILIA. 2022;28(4):548. http://www.ncbi.nlm.nih.gov/pubmed/35475308?dopt=Citation.

Pfeilschifter W, Lindhoff-Last E, Alhashim A, Zydek B, Lindau S, Konstantinides S, Grottke O, Nowak-Göttl U, von Heymann C, Birschmann I, Beyer-Westendorf J, Meybohm P, Greinacher A, Herrmann E, RADOA-Registry Investigators (Reversal Agent use in patients treated with Direct Oral Anticoagulants or vitamin K antagonists Registry). Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry. Neurol Res Pract. 2022;4(1):16.
http://www.ncbi.nlm.nih.gov/pubmed/35491419?dopt=Citation.

Lindhoff-Last E, Birschmann I, Kuhn J, Lindau S, Konstantinides S, Grottke O, Nowak-Göttl U, Lucks J, Zydek B, von Heymann C, Sümnig A, Beyer-Westendorf J, Schellong S, Meybohm P, Greinacher A, Herrmann E, RADOA-Registry Investigators (Reversal Agent use in patients treated with Direct Oral Anticoagulants or vitamin K antagonists Registry). Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry. THROMB HAEMOSTASIS. 2022;122(4):552. http://www.ncbi.nlm.nih.gov/pubmed/34256392?dopt=Citation.

Lindhoff-Last E, Birschmann I, Bidenharn AJ, Kuhn J, Lindau S, Konstantinides S, Grottke O, Nowak-Göttl U, Lucks J, Zydek B, von Heymann C, Sümnig A, Beyer-Westendorf J, Schellong S, Meybohm P, Greinacher A, Herrmann E, RADOA-Registry Investigators. Pharmacokinetics of Phenprocoumon in Emergency Situations-Results of the Prospective Observational RADOA-Registry (Reversal Agent Use in Patients Treated with Direct Oral Anticoagulants or Vitamin K Antagonists Registry). Pharmaceuticals (Basel). 2022;15(11). http://www.ncbi.nlm.nih.gov/pubmed/36422567?dopt=Citation.

Panholzer B, Pilarczyk K, Huenges K, Aldinger C, Friedrich C, Nowak-Göttl U, Cremer J, Haneya A. Severe Pulmonary Bleeding after Assist Device Implantation: Incidence, Risk Factors and Prognostic Impact. J CLIN MED. 2022;11(7). http://www.ncbi.nlm.nih.gov/pubmed/35407516?dopt=Citation.

Limperger V, Torge A, Kiesau B, Langer F, Kenet G, Mesters R, Juhl D, Stoll M, Shneyder M, Kowalski D, Bajorat T, Rocke A, Kuta P, Lasarow L, Spengler D, Junker R, Nowak-Göttl U. Validation of a predictive model for identifying an increased risk for recurrence in adolescents and young adults with a first provoked thromboembolism. BLOOD CELL MOL DIS. 2022;94:102651. http://www.ncbi.nlm.nih.gov/pubmed/35051688?dopt=Citation

Juhl D, Kuta P, Shneyder M, Wünsche F, Nowak-Göttl U. Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia. ACTA HAEMATOLOGICA 2021;144 (2):222-226.

Neuner B, von Mackensen S, Kiesau B, Krampe H, McCarthy WJ, Reinke S, Kowalski D, Shneyder M, Clausnizer H, Rocke A, Junker R, Nowak-Göttl U. Cross-Sectional and Longitudinal Construct Validity of the Generic KINDL-A(dult)B(rief) Questionnaire in Adults with Thrombophilia or with Hereditary and Acquired Bleeding Disorders. ACTA HAEMATOLOGICA 2021; 144(2):166-175.

Panholzer B, Bajorat T, Haneya A, Kowalski D, Juhl D, Rocke A, Shneyder M, Kuta P, Clausnizer H, Junker R, Kowalski A, Tulun A, Al-Suraimi A, Cremer J, Kalbhenn J, Zieger B, Nowak-Göttl U. Acquired von Willebrand syndrome in ECMO patients: A 3-year cohort study. BLOOD CELLS MOLECULES AND DISEASES / März / 0-0

Zheng T, Ellinghaus D, Juzenas S, Cossais F, Burmeister G, Mayr G, Jørgensen IF, Teder-Laving M, Skogholt AH, Chen S, Strege PR, Ito G, Banasik K, Becker T, Bokelmann F, Brunak S, Buch S, Clausnitzer H, Datz C; DBDS Consortium, Degenhardt F, Doniec M, Erikstrup C, Esko T, Forster M, Frey N, Fritsche LG, Gabrielsen ME, Gräßle T, Gsur A, Gross J, Hampe J, Hendricks A, Hinz S, Hveem K, Jongen J, Junker R, Karlsen TH, Hemmrich-Stanisak G, Kruis W, Kupcinskas J, Laubert T, Rosenstiel PC, Röcken C, Laudes M, Leendertz FH, Lieb W, Limperger V, Margetis N, Mätz-Rensing K, Németh CG, Ness-Jensen E, Nowak-Göttl U, Pandit A, Pedersen OB, Peleikis HG, Peuker K, Rodriguez CL, Rühlemann MC, Schniewind B, Schulzky M, Skieceviciene J, Tepel J, Thomas L, Uellendahl-Werth F, Ullum H, Vogel I, Volzke H, von Fersen L, von Schönfels W, Vanderwerff B, Wilking J, Wittig M, Zeissig S, Zobel M, Zawistowski M, Vacic V, Sazonova O, Noblin ES; 23andMe Research Team, Farrugia G, Beyder A, Wedel T, Kahlke V, Schafmayer C, D'Amato M, Franke A. Genome-wide analysis of 944 133 individuals provides insights into the etiology of haemorrhoidal disease. GUT / 70 / 1538-1549

Herken K, Glauner M, Robert SC, Maas M, Zippel S, Nowak-Göttl U, Zieger B, Lahav J, Fender AC, Jurk K, Kehrel BE. Age-Dependent Control of Collagen-Dependent Platelet Responses by Thrombospondin-1-Comparative Analysis of Platelets from Neonates, Children, Adolescents, and Adults. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES / Mai / 0-0

van Ommen CH, Albisetti M, Bhatt M, Bonduel M, Branchford B, Chalmers E, Chan A, Goldenberg NA, Holzhauer S, Monagle P, Nowak-Göttl U, Revel-Vilk S, Sciuccatie G, Sirachainan N, Male C. International pediatric thrombosis network to advance pediatric thrombosis research: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. JOURNAL OF THROMBOSIS AND HAEMOSTASIS / 19 / 1123-1129

Limperger, V; Kenet, G; Kiesau, B; Köther, M;Schmeiser, M; Langer, F; Juhl, D; Shneyder, M; Franke, A; Klostermeier, Ulich K. Role of prothrombin 19911 A> G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort study. JOURNAL OF THROMBOSIS AND THROMBOLYSIS / 51 / 494−501

Herrera-Rivero M, Stoll M, Hegenbarth JC, Rühle F, Limperger V, Junker R, Franke A, Hoffmann P, Shneyder M, Stach M, Nowak-Göttl U. Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous Thromboembolism. THROMBOSIS AND HAEMOSTASIS / 121 / 1169−1180

Lindhoff-Last E, Birschmann I, Kuhn J, Lindau S, Konstantinides S, Grottke O, Nowak-Göttl U, Lucks J, Zydek B, von Heymann C, Sümnig A, Beyer-Westendorf J, Schellong S, Meybohm P, Greinacher A, Herrmann E. Pharmacokinetics of Direct Oral Anticoagulants in Emergency Situations: Results of the Prospective Observational RADOA-Registry. THROMBOSIS AND HAEMOSTASIS / Juli / 0−0

Neuner B, von Mackensen S, Kiesau B, Krampe H, McCarthy WJ, Reinke S, Kowalski D, Shneyder M, Clausnizer H, Rocke A, Junker R, Nowak-Göttl U. (2020) Cross-Sectional and Longitudinal Construct Validity of the Generic KINDL-A(dult)B(rief) Questionnaire in Adults with Thrombophilia or with Hereditary and Acquired Bleeding Disorders.  Acta Haematol. 1-9. doi: 10.1159/000507602. Online ahead of print. PMID: 32506056

Witten A, Rühle F, de Witt M, Barysenka A, Stach M, Junker R, Nowak-Göttl U, Stoll M. ADAMTS12, a new candidate gene for pediatric stroke. (2020) PLoS One. 15(8): e0237928. Published online 2020 Aug 20. doi: 10.1371/journal.pone.0237928

Juhl D, Kuta P, Shneyder M, Wünsche F, Nowak-Göttl U. (2020) Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia. Acta Haematol. 10:1-4. doi: 10.1159/000508525. Online ahead of print. PMID: 32653888

Hartmann S, Biliouris K, Lesko LJ, Nowak-Göttl U, Trame MN. (2020) Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy.  Front Pharmacol. 11:1041. doi: 10.3389/fphar.2020.01041. eCollection 2020. PMID: 32765265

Goeggel Simonetti B, Rafay MF, Chung M, Lo WD, Beslow LA, Billinghurst LL, Fox CK, Pagnamenta A, Steinlin M, Mackay MT; IPSS Study Group (Nowak-Göttl U). (2020) Comparative study of posterior and anterior circulation stroke in childhood: Results from the International Pediatric Stroke Study. Neurology. 2020 Jan 28;94(4):e337-e344. doi: 10.1212/WNL.0000000000008837. Epub 2019 Dec 19. PMID: 31857436

Lindhoff-Last E, Herrmann E, Lindau S, Konstantinides S, Grottke O, Nowak-Goettl U, Lucks J, Zydek B, Heymann CV, Birschmann I, Sümnig A, Beyer-Westendorf J, Schellong S, Meybohm P, Greinacher A. (2020) Severe Hemorrhage Associated With Oral Anticoagulants. Dtsch Arztebl Int. 2020 May 1;117(18):312-319. doi: 10.3238/arztebl.2020.0312. PMID: 32605708

Male C, Lensing AWA, Palumbo JS, Kumar R, Nurmeev I, Hege K, Bonnet D, Connor P, Hooimeijer HL, Torres M, Chan AKC, Kenet G, Holzhauer S, Santamaría A, Amedro P, Chalmers E, Simioni P, Bhat RV, Yee DL, Lvova O, Beyer-Westendorf J, Biss TT, Martinelli I, Saracco P, Peters M, Kállay K, Gauger CA, Massicotte MP, Young G, Pap AF, Majumder M, Smith WT, Heubach JF, Berkowitz SD, Thelen K, Kubitza D, Crowther M, Prins MH, Monagle P; EINSTEIN-Jr Phase 3 Investigators (Nowak-Göttl U). (2020) Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 2020 Jan;7(1):e18-e27. doi: 10.1016/S2352-3026(19)30219-4. Epub 2019 Nov 5. PMID: 31699660 Clinical Trial.

Weimar C, Holzhauer S, Knoflach M, Koennecke HC, Masuhr F, Mono ML, Niederstadt T, Nowak-Göttl U, Schellong SM, Kurth T: [Cerebral venous and sinus thrombosis: S2k guidelines]. Nervenarzt. 2019 Apr;90(4):379-387. doi:10.1007/s00115-018-0654-6. Review. German. PubMed PMID: 30758512.

Nowak-Göttl U, Miesbach W, Koscielny J, Dempfle CE, Maegele M, ProndzinskiMVD, Westrup D, Spannagl M: Replacement Therapy in Patients with Von WillebrandDisease-Indications and Monitoring. Hamostaseologie. 2019 Nov;39(4):326-338. doi:10.1055/s-0039-1692688. Epub 2019 Jul 30. PubMed PMID: 31364093.

Monagle P, Lensing AWA, Thelen K, Martinelli I, Male C, Santamaría A,Samochatova E, Kumar R, Holzhauer S, Saracco P, Simioni P, Robertson J, Grangl G,Halton J, Connor P, Young G, Molinari AC, Nowak-Göttl U, Kenet G, Kapsa S,Willmann S, Pap AF, Becka M, Twomey T, Beyer-Westendorf J, Prins MH, Kubitza D: EINSTEIN-Jr Phase 2 Investigators. Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre,single-arm, phase 2 studies. Lancet Haematol. 2019 Oct;6(10):e500-e509. oi:10.1016/S2352-3026(19)30161-9. Epub 2019 Aug 13. PubMed PMID: 31420317.

Kenet G, Cohen O, Bajorat T, Nowak-Göttl U: Insights into neonatal thrombosis.Thromb Res. 2019 Sep;181 Suppl 1:S33-S36. doi: 10.1016/S0049-3848(19)30364-0.Review. PubMed PMID: 31477225.

deVeber G, Kirkham F, Shannon K, Brandão L, Sträter R, Kenet G, Clausnizer H, Moharir M, Kausch M, Askalan R, MacGregor D, Stoll M, Torge A, Dlamini N, GanesanV, Prengler M, Singh J, Nowak-Göttl U. Recurrent stroke: the role ofthrombophilia in a large international pediatric stroke population.Haematologica. 2019 Aug;104(8):1676-1681. doi: 10.3324/haematol.2018.211433. Epub 2019 Jan 24. Erratum in: Haematologica. 2019 Oct;104(10):2116. PubMed PMID:0679327; PubMed Central PMCID: PMC6669164.

Nowak-Göttl U, van Ommen H, Kenet G: Thrombophilia testing in children: What and when should be tested? Thromb Res 2018; 164: 75-8.

Kenet G, Barg AA, Nowak-Göttl U: Hemostasis in the Very Young. Semin Thromb Hemost 2018; doi: 10.1055/s-0038-1660852. Epub 2018 Jun 18.

Lensing AWA, Male C, Young G, Kubitza D, Kenet G, Patricia Massicotte M, Chan A, Molinari AC, Nowak-Göttl U, Pap ÁF, Adalbo I, Smith WT, Mason A, Thelen K, Berkowitz SD, Crowther M, Schmidt S, Price V, Prins MH, Monagle P. Rivaroxaban versus standard anticoagulation for acute venous thromboembolism in childhood. Design of the EINSTEIN-Jr phase III study. Thromb J. 2018 Dec 21;16:34. doi: 10.1186/s12959-018-0188-y. eCollection 2018. PubMed PMID: 30598642; PubMed Central PMCID: PMC6302520.

Juhl D, Nowak-Göttl U, Blümel J, Görg S, Hennig H. Lack of evidence for the transmission of hepatitis E virus by coagulation factor concentrates based on seroprevalence data. Transfus Med. 2018 Dec;28(6):427-432. doi:10.1111/tme.12498. Epub 2017 Dec 27. PubMed PMID: 29280212.

Witten A, Bolbrinker J, Barysenka A, Huber M, Rühle F, Nowak-Göttl U, Garbe E, Kreutz R, Stoll M: Targeted resequencing of a locus for heparin-induced thrombocytopenia on chromosome 5 identified in a genome-wide association study. J Mol Med 2018; doi: 10.1007/s00109-018-1661-6. Epub 2018 Jun 22.

Neuner B, Krampe H, McCarthy WJ, Reinke S, Kowalski D, Clausnizer H, Shneyder M, Rocke A, Nowak-Göttl U: Psychometric Properties of a Modified KINDL-R Questionnaire for Adolescents and Adults, and Construction of a Brief Version, the KINDL-A(dult)B(rief) Questionnaire, KINDL-AB. Acta Haematol 2018; 140: 1-9.

Sultan S, Dowling M, Kirton A, DeVeber G, Linds A, Elkind MSV; IPSS Investigators. Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence and Risk Factors. Pediatr Neurol. 2018 Jan;78:46-54. doi 10.1016/j.pediatrneurol.2017.09.019. Epub 2017 Oct 10. PubMed PMID: 29229232; PubMed Central PMCID: PMC5776751.

Juhl D, Nowak-Göttl U, Blümel J, Görg S, Hennig H: Lack of evidence for the transmission of hepatitis E virus by coagulation factor concentrates based on seroprevalence data. Transfus Med 2017; doi: 10.1111/tme.12498. Epub 2017 Dec 27.

Nowak-Göttl U, Dietrich K, Kruempel A, Geisen C, Mitchell LG: The VKORC1 and CYP2C9 genotypes significantly effect Vitamin K antagonist dosing only in patients over the age of 20years. Blood Cells Mol Dis 2017; 67: 54-8.

Kenet G, Nowak-Göttl U: Editorial for special pediatric hemostasis issue BCMD. Blood Cells Mol Dis. 2017; 67: 1.

Boeckelmann D, Hengartner H, Greinacher A, Nowak-Göttl U, Sachs UJ, Peter K, Sandrock-Lang K, Zieger B: Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype. Blood Cells Mol Dis 2017; 67: 69-74.

Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, Clausnizer H, Liebsch J, Junker R, Steppat D: Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67: 2-13.

Strauss T, Elisha N, Ravid B, Rosenberg N, Lubetsky A, Levy-Mendelovich S, Morag I, Nowak-Göttl U, Kenet G: Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Blood Cells Mol Dis 2017; 67: 14-7.

Kenet G, Limperger V, Shneyder M, Nowak-Göttl U: Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20 years? Blood Cells Mol Dis 2017; 67: 18-22.

Nowak-Göttl U, Clausnizer H, Kowalski D, Limperger V, Krümpel A, Shneyder M, Reinke S, Rocke A, Juhl D, Steppat D, Krause M: Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disorders. Blood Cells Mol Dis 2017; 67: 96-101.

Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, Clausnizer H, Liebsch J, Junker R, Steppat D: Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67: 2-13.

van Ommen CH, Nowak-Göttl U: Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test. Front Pediatr 2017; 5: 50.

Sultan S, Dowling M, Kirton A, DeVeber G, Linds A, Elkind MSV; IPSS Investigators: Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence and Risk Factors. Pediatr Neurol 2018; 78: 46-54.

Rühle F, Witten A, Barysenka A, Huge A, Arning A, Heller C, Krümpel A, Mesters R, Franke A, Lieb W, Riemenschneider M, Hiersche M, Limperger V, Nowak-Göttl U, Stoll M: Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism. Blood 2017; 129: 783-90.

Bernard TJ, Poisson S, Branchford BR,  Nowak-Göttl U: Coagulation Disorders and Cerebrovascular Disease in Children. In: Swaiman KF, Ashwal S, Ferriero DM, Schor NF, Finkel RS,  Gropman AL,  Pearl  PL , Shevell M: Swaiman's Pediatric Neurology. New York City: Elsiver 2017; 2007-2017.

Kreuz W., Escuriola Ettingshausen C., Vdovin V., Zozulya N., Plyushch O., Svirin .P, Andreeva T., Bubanská E., Campos M., Benedik-Dolničar M., Jiménez-Yuste V., Kitanovski L., Klukowska A., Momot A., Osmulskaya N., Prieto M., Šalek S.Z., Velasco F., Pavlova A.,Oldenburg J., Knaub S., Jansen M., Belyanskaya L., Walter O.; ObsITI study group.; ObsITI committee. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study. Haemophilia. 2016 Jan;22(1):87-95. doi: 10.1111/hae.12774. PubMed PMID: 26202305.

Arning A., Jeibmann A., Köhnemann S., Brokinkel B., Ewelt C., Berger K., Wellmann J., Nowak-Göttl U., Stummer W., Stoll M., Holling M. ADAMTS genes and the risk of cerebral aneurysm. J Neurosurg. 2016 Aug;125(2):269-74. doi: 10.3171/2015.7.JNS154.

Werwitzke S, Geisen U, Nowak-Göttl U, Eichler H, Stephan B, Scholz U, Holstein K, Klamroth R, Knöbl P, Huth-Kühne A, Bomke B, Tiede A. Diagnostic and prognostic value of factor VIII binding antibodies in acquired hemophilia A: data from the GTH-AH 01/2010 study. J. Thromb. Haemost. 2016 May;14(5):940-7. doi: 10.1111/jth.13304. Epub 2016 Apr 22.

Neuner B, von Mackensen S, Holzhauer S, Funk S, Klamroth R, Kurnik K, Krümpel A, Halimeh S, Reinke S, Frühwald M, Nowak-Göttl U. Health-Related Quality of Life in Children and Adolescents with Hereditary Bleeding Disorders and in Children and Adolescents with Stroke: Cross-Sectional Comparison to Siblings and Peers. Biomed. Res. Int. 2016;2016:1579428. doi: 10.1155/2016/1579428. Epub 2016 May 15.

Limperger V., Kenet G., Goldenberg N.A., Heller C., Holzhauer S., Junker R., Klostermeier U.C., Knoefler R., Kurnik K., Krümpel A., Mesters R., Stach M., Young G., Nowak-Göttl U. Impact of high-risk thrombophilia status on recurrence among children with a first non-central-venous-catheter-associated VTE: an observational multicentre cohort study. Br J Haematol. 2016 Oct;175(1):133-40. doi: 10.1111/bjh.14192.

Stoll M., Rühle F., Witten A., Barysenka A., Arning A., Strauss C., Nowak-Göttl U. Rare Variants in the ADAMTS13 VWF Binding Domain Contribute to Pediatric Stroke. Circ Cardiovasc Genet. 2016 Aug;9(4):357-67. doi: 10.1161/CIRCGENETICS.115.001184.

Nowak-Göttl U., Kehrel B.E. Haemostasis - an indispensable, cross.sectional medical discipline. Thromb Haemost. 2016 Sep 27;116(4):595-6. doi: 10.1160/TH16-08-0648. No abstract available.

Hartmann S., Biliouris K., Lesko L..J, Nowak-Göttl U., Trame M.N. Quantitative Systems Pharmacology Model to Predict the Effect of Commonly Used Anticoagulants on the Human Coagulation Network. CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):554-564. doi: 10.1002/psp4.12111.

Brüwer G., Limperger V., Kenet G., Klostermeier U.C., Shneyder M., Degenhardt F., Finckh U., Heller C., Holzhauer S., Trappe R., Kentouche K., Knoefler R., Kurnik K., Krümpel A., Lauten M., Manner D., Mesters R., Junker R., Nowak-Göttl U. Impact of high rist thrombophilia status of recurrence among children and adults with VTE: An observational multicenter cohort study. Blood Cells Mol Dis. 2016 Nov;62:24-31. doi: 10.1016/j.bcmd.2016.10.024.

Nowak-Göttl U., Clausnizer H., Kowalski D., Limperger V., Krümpel A,. Shneyder M., Reinke S., Rocke A., Juhl D., Steppat D., Krause M. Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disorders.Blood Cells Mol Dis. 2016 Nov 12. pii: S1079-9796(16)30165-6. doi: 10.1016/j.bcmd.2016.11.010. [Epub ahead of print]

Krause M., Henningsen A., Torge A., Juhl D., Junker R., Kenet G., Kowalski D., Limperger V., Mesters R., Anonymous, Rocke A., Shneyder M., Clausnizer H., Schiesewitz H., Nowak-Göttl U. Impact of gender on safty and efficacy of Rivaroxaban in adolescents & young adults with venous tromboembolism. Thromb Res. 2016 Dec;148:145-151. doi: 10.1016/j.thromres.2016.09.007.

Nowak-Göttl U., Limperger V., Kenet G., Degenhardt .F, Arlt R., Domschikowski J.,Clausnizer H., Liebsch J., Junker R., Steppat D. Developmental hemostasis: Alifespan from neonates and pregnancy to the young and elderly adult in a Europeanwhite population. Blood Cells Mol Dis. 2016 Dec 5. pii: S1079-9796(16)30268-6.doi: 10.1016/j.bcmd.2016.11.012. [Epub ahead of print] PubMed PMID: 28017497.

Kenet G., Limperger V., Shneyder M., Nowak-Göttl U.. Risk factors for symptomaticvenous and arterial thromboembolism in newborns, children and adolescents - Whatdid we learn within the last 20years? Blood Cells Mol Dis. 2016 Dec 14. pii:S1079-9796(16)30274-1. doi: 10.1016/j.bcmd.2016.12.003. [Epub ahead of print]PubMed PMID: 28010922.

Rühle F., Witten A., Barysenka A., Huge A., Arning A., Heller C., Krümpel A.,Mesters R., Franke A., Lieb W., Riemenschneider M., Hiersche M., Limperger V., Nowak-Göttl U., Stoll M. Rare genetic variants in SMAP1, B3GAT2 and RIMS1contribute to pediatric venous thromboembolism. Blood. 2016 Dec 23. pii:blood-2016-07-728840. doi: 10.1182/blood-2016-07-728840. [Epub ahead of print]PubMed PMID: 28011674.

Strauss T., Elisha N., Ravid B., Rosenberg N., Lubetsky A., Levy-Mendelovich S., Morag I., Nowak Göttl U., Kenet G. Activity of Von Willebrand factor and levels of  VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Blood Cells Mol Dis. 2016 Dec 29. pii: S1079-9796(16)30161-9. doi: 10.1016/j.bcmd.2016.12.013. [Epub ahead of print] PubMed PMID: 28087247.